Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells

Journal of Biochemistry

Volumn 143, Issue 2, 2008, Pages 179-186

  Balestrieri, Maria Luisa ^a   Schiano, Concetta ^a   Felice, Francesca ^a   Casamassimi, Amelia ^a   Balestrieri, Antonio ^a   Milone, Lara ^a   Servillo, Luigi ^a   Napoli, Claudio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antioxidants; Endothelial progenitor cells; Red wine; Resveratrol

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE P38; RESVERATROL; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NEOVASCULARIZATION (PATHOLOGY); PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RED WINE; STEM CELL;

BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; STEM CELLS; STILBENES; TUMOR NECROSIS FACTOR-ALPHA; WINE;

EID: 39149085689     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvm209     Document Type: Article

References (53)

1. Peichev, M., Naiyer, A.J., Pereira, D., Zhu, Z., Lane, W.J., Williams, M., Oz, M.C., Hicklin, D.J., Witte, L., Moore, M.A., and Rafii, S. (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95, 952-958
2. Urbich, C., Heeschen, C., Aicher, A., Dernbach, E., Zeiher, A.M., and Dimmeler, S. (2003) Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108, 2511-2516
3. Yoder, M.C., Mead, L.E., Prater, D., Krier, T.R., Mroueh, K.N., Li, F., Krasich, R., Temm, C.J., Prchal, J.T., and Ingram, D.A. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/ progenitor cell principals. Blood 109, 1801-1809
4. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., and Isner, J.M. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967
5. Takahashi, T., Kalka, C., Masuda, H., Chen, D., Silver, M., Kearney, M., Magner, M., Isner, J.M., and Asahara, T. (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5, 434-438
6. Shantsila, F., Watson, T., and Lip, G.Y. (2007) Endothelial progenitor cells in cardiovascular disorders. J. Am. Coll. Cardiol. 49, 741-752
7. Urbich, C. and Dimmeler, S. (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95, 343-353
8. Napoli, C., Maione, C., Schiano, C., Fiorito, C., and Ignarro, L.J. (2007) Bone marrow cell-mediated cardiovascular repair: potential of combined therapies. Trends Mol. Med. 13, 278-286
9. Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H., Zeiher, A.M., and Dimmeler, S. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89, E1-E7
10. Hill, J.M., Zalos, G., Halcox, J.P., Schenke, W.H., Waclawiw, M.A., Quyyumi, A.A., and Finkel, T. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593-600
11. Tepper, O.M., Galiano, R.D., Capla, J.M., Kalka, C., Gagne, P.J., Jacobowitz, G.R., Levine, J.P., and Gurtner, G.C. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106, 2781-2786
12. Paul, J.D., Powell, T.M., Thompson, M., Benjamin, M., Rodrigo, M., Carlow, A., Annavajjhala, V., Shiva, S., Dejam, A., Gladwin, M.T., McCoy, J.P., Zalos, G., Press, B., Murphy, M., Hill, J.M., Csako, G., Waclawiw, M.A., and Cannon, R.O.III. (2007) Endothelial progenitor cell mobilization and increased intravascular nitric oxide in patients undergoing cardiac rehabilitation. J. Cardiopulm. Rehabil. Prev. 27, 65-73
13. Gallagher, K.A., Liu, Z.J., Xiao, M., Chen, H., Goldstein, L.J., Buerk, D.G., Nedeau, A., Thom, S.R., and Velazquez, O.C. (2007) Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J. Clin. Invest. 117, 1249-1259
14. Westenbrink, B.D., Lipsic, E., van der Meer, P., van der Harst, P., Oeseburg, H., Du, Marchie, Sarvaas, G.J., Koster, J., Voors, A.A., van Veldhuisen, D.J., van Gilst, W.H., Schoemaker, R.G., Westenbrink, B.D. et al. (2007) Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization. Eur. Heart. J. 28, 2018-2027
15. Dimmeler, S., Aicher, A., Vasa, M., Mildner-Rihm, C., Adler, K., Tiemann, M., Rutten, H., Fichtlscherer, S., Martin, H., and Zeiher, A.M. (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest. 108, 391-397
16. Hamada, H., Kim, M.K., Iwakura, A., Ii, M., Thorne, T., Qin, G., Asai, J., Tsutsumi, Y., Sekiguchi, H., Silver, M., Wecker, A., Bord, E., Zhu, Y., Kishore, R., and Losordo, D.W. (2006) Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation 114, 2261-2270
17. Gensch, C., Clever, Y.P., Werner, C., Hanhoun, M., Bohm, M., and Laufs, U. (2007) The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells. Atherosclerosis 192, 67-74
18. Pistrosch, F., Herbrig, K., Oelschlaegel, U., Richter, S., Passauer, J., Fischer, S., and Gross, P. (2005) PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis 183, 163-167
19. Opie, L.H. and Lecour, S. (2007) The red wine hypothesis: from concepts to protective signalling molecules. Eur. Heart J. 28, 1683-1693
20. Corder, R., Mullen, W., Khan, N.Q., Marks, S.C., Wood, E.G., Carrier, M.J., and Crozier, A. (2006) Oenology: red wine procyanidins and vascular health. Nature 444, 566
21. Curin, Y. and Andriantsitohaina, R. (2005) Polyphenols as potential therapeutical agents against cardiovascular diseases. Pharmacol. Rep. 57, 97-107
22. Leikert, J.F., Rathel, T.R., and Wohlfart, P. (2002) Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 106, 1614-1617
23. Wallerath, T., Poleo, D., Li, H., and Forstermann, U. (2003) Red wine increases the expression of human endothelial nitric oxide synthase. J. Am. Coll. Cardiol. 41, 471-478
24. Corder, R., Douthwaite, J.A., Lees, D.M., Khan, N.Q., Viseu Dos Santos, A.C., Wood, E.G., and Carrier, M.J. (2001) Endothelin-1 synthesis reduced by red wine. Nature 414, 863-864
25. Frankel, E.N., Kanner, J., German, J.B., Parks, E., and Kinsella, J.E. (1993) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341, 454-457
26. Baron-Menguy, C., Bocquet, A., Guihot, A.L., Chappard, D., Amiot, M.J., Andriantsitohaina, R., Loufrani, L., and Henrion, D. (2007) Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic. FASEB J. 21, 3511-3521
27. Lefevre, J., Michaud, S.E., Haddad, P., Dussault, S., Menard, C., Groleau, J., Turgeon, J., and Rivard, A. (2007) Moderate consumption of red wine (cabernet sauvignon) improves ischemia-induced neovascularization in ApoE-deficient mice: effect on endothelial progenitor cells and nitric oxide. FASEB J.Jul 19; [Epub ahead of print] PMID: 17641150
28. Szmitko, P.E. and Verma, S. (2005) Antiatherogenic potential of red wine: clinician update. Am. J. Physiol. Heart Circ. Physiol. 288, H2023-H2030
29. Ignarro, L.J., Balestrieri, M.L., and Napoli, C. (2007) Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc. Res. 73, 326-340
30. Djoussé, L. and Gaziano, J.M. (2007) Alcohol consumption and risk of heart failure in the physicians' health study I. Circulation 115, 34-39
31. de Nigris, F., Lerman, L.O., Ignarro, S-W., Sica, G., Lerman, A., Palinski, W., Ignarro, L.J., and Napoli, C. (2003) Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress. Proc. Natl. Acad. Sci. USA 100, 1420-1425
32. de Nigris, F., Ignarro, S-W., Lerman, L.O., Crimi, E., Botti, C., Mansueto, G., D'Armiento, F.P., De Rosa, G., Sica, V., Ignaro, L.J., and Napoli, C. (2005) Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress. Proc. Natl. Acad. Sci. USA. 102, 4896-4901
33. Napoli, C., Balestrieri, M.L., Sica, V., Lerman, L.O., Crimi, E., Gaetano De Rosa, G., Balestrieri, A., Schiano, C., Servillo, L., and D'Armiento, F.P. (2007) Beneficial effects of low doses of red wine consumption on perturbed shear stress-induced atherogenesis. Heart Vessels, In press
34. Singleton, V.L and Rossi, J.A. (1965) Colorimetry of total phenols with phosphomolybdic-phosphotungstic acid reagent. Am. J. Enol. Vitic. 16, 144-158
35. Benzie, I.F. and Strain, J.J. (1996) The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP Assay. Anal. Biochem. 239, 70-76
36. Ratola, N., Faria, J.L., and Alves, A. (2004) Analysis and quantification of trans-resveratrol in wines from Alentejo Region (Portugal). Food Technol. Biothechnol. 42, 125-130
37. Casamassimi, A., Balestrieri, M.L., Fiorito, C., Schiano, C., Maione, C., Rossiello, R., Grimaldi, V., Del Giudice, V., Balestrieri, C., Farzati, B., Sica, V., and Napoli, C. (2007) Comparison between total endothelial progenitor cells isolation versus enriched CD133+ culture. J. Biochem. 141, 503-511
38. Seeger, F.H., Haendeler, J., Walter, D.H., Rochwalsky, U., Reinhold, J., Urbich, C., Rossig, L., Corbaz, A., Chvatchko, Y., Zeiher, A.M., and Dimmeler, S. (2005) p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111, 1184-1191
39. Napoli, C., Williams-Ignarro, S., de Nigris, F., Lerman, L.O., D'Armiento, F.P., Crimi, E., Byrns, R.E., Casamassimi, A., Lanza, A., Gombos, F., Sica, V., and Ignarro, L.J. (2006) Physical training and metabolic supplementation reduce spontaneous atherosclerotic plaque rupture and prolong survival in hypercholesterolemic mice. Proc. Natl Acad. Sci. USA 103, 10479-10484
40. Kroon, P.A., Clifford, M.N., Crozier, A., Day, A.J., Donovan, J.L., Manach, C., and Williamson, G. (2004) How should we assess the effects of exposure to dietary polyphenols in vitro? Am. J. Clin. Nutr. 80, 15-21
41. Gambuti, A., Strollo, D., Ugliano, M., Lecce, L., and Moio, L. (2004) trans-Resveratrol, quercetin, (+)-catechin, and (-)-epicatechin content in south Italian monovarietal wines: relationship with maceration time and marc pressing during winemaking. J. Agric. Food. Chem. 52, 5747-5751
42. Cheynier, V. (2005) Polyphenols in foods are more complex than often thought. Am. J. Clin. Nutr. 81, 223S-229S
43. Räthel, T.R., Samtleben, R., Vollmar, A.M., and Dirsch, V.M. (2007) Activation of endothelial nitric oxide synthase by red wine polyphenols: impact of grape cultivars, growing area and the vinification process. J. Hypertens. 25, 541-549
44. J G, Cq, W., Hh, F., Hy, D., Xl, X., Ym, X., By, W., and Dj, H. (2006) Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intima-injured rats. J. Cardiovasc. Pharmacol. 47, 711-721
45. Zou, J., Huang, Y., Cao, K., Yang, G., Yin, H., Len, J., Hsieh, T.C., and Wu, J.M. (2000) Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit model. Life Sci. 68, 153-163
46. Appeldoorn, C.C., Bonnefoy, A., Lutters, B.C., Daenens, K., van Berkel, T.J., Hoylaerts, M.F., and Biessen, E.A. (2005) Gallic acid antagonizes P-selectin-mediated plateletleukocyte interactions: implications for the French paradox. Circulation 111, 106-112
47. Pignatelli, P., Ghiselli, A., Buchetti, B., Carnevale, R., Natella, F., Germano, G., Fimognari, F., Di Santo, S., Lenti, L., and Violi, F. (2006) Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis 188, 77-83
48. Rajdl, D., Racek, J., Trefil, L., and Siala, K. (2007) Effect of white wine consumption on oxidative stress markers and homocysteine levels. Physiol. Res. 56, 203-212
49. Laufs, U., Werner, N., Link, A., Endres, M., Wassmann, S., Jurgens, K., Miche, E., Bohm, M., and Nickenig, G. (2004) Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109, 220-226
50. Steiner, S., Niessner, A., Ziegler, S., Richter, B., Seidinger, D., Pleiner, J., Penka, M., Wolzt, M., Huber, K., Wojta, J., Minar, E., and Kopp, C.W. (s2005) Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. Atherosclerosis 181, 305-310
51. Napoli, C., Balestrieri, A., and Ignarro, L.J. (2007) Therapeutic approaches in vascular repair induced by adult bone marrow cells and circulating progenitor endothelial cells. Curr. Pharm. Des. 13, 3245-3251
52. Napoli, C., Williams-Ignarro, S., De Nigris, F., Lerman, L.O., Rossi, L., Guarino, C., Mansueto, G., Di Tuoro, F., Pignalosa, O., De Rosa, G., Sica, V., and Ignarro, L.J. (2004) Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc. Natl Acad. Sci. USA 101, 8797-8802
53. Chen, J., Wang, X., Zhu, J., Shang, Y., Guo, X., and Sun, J. (2004) Effects of Ginkgo biloba extract on number and activity of endothelial progenitor cells from peripheral blood. J. Cardiovasc. Pharmacol. 43, 347-352